Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00662558Phase 3Completed
Phase 3, randomised, double-blind trial of celecoxib in low back pain (LBP), sponsored by Viatris. Primary endpoint: Treatment Responders Based on the Numerical Rating Scale-Pain at 6 weeks. Started Jan 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00662558.